182 related articles for article (PubMed ID: 7594097)
1. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
[TBL] [Abstract][Full Text] [Related]
2. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
4. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
[TBL] [Abstract][Full Text] [Related]
5. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
[TBL] [Abstract][Full Text] [Related]
6. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
[TBL] [Abstract][Full Text] [Related]
7. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
10. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
Bittl JA; Ahmed WH
Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
[TBL] [Abstract][Full Text] [Related]
11. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe MT; Granger CB; Puma JA; Hellkamp AS; Hochman JS; Ohman EM; White HD; Van de Werf F; Armstrong PW; Ellis SG; Califf RM; Topol EJ
Am J Cardiol; 2001 Dec; 88(12):1403-6, A6. PubMed ID: 11741559
[No Abstract] [Full Text] [Related]
12. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Feit F
Am J Cardiol; 1998 Oct; 82(8B):43P-49P. PubMed ID: 9809891
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
[TBL] [Abstract][Full Text] [Related]
14. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
Cannon CP; Braunwald E
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
Circulation; 1997 Aug; 96(3):769-77. PubMed ID: 9264481
[TBL] [Abstract][Full Text] [Related]
16. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
17. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.
Bittl JA; Chaitman BR; Feit F; Kimball W; Topol EJ
Am Heart J; 2001 Dec; 142(6):952-9. PubMed ID: 11717596
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions.
Shah PB; Ahmed WH; Ganz P; Bittl JA
J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925
[TBL] [Abstract][Full Text] [Related]
20. The ill wind of transient vessel closure during percutaneous transluminal coronary angioplasty.
Block PC
J Am Coll Cardiol; 1999 Jan; 33(1):79-81. PubMed ID: 9935012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
